Project
SAKK 06/17
Ongoing - recruitment closed · 2018 until 2099
Aeppli Stefanie, Breuss Kim, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2018
End Date
2099
Financing
SAKK
Labels
bladder cancer
Brief description/objective
Neoadjuvant and adjuvant durvalumab in combination with neoadjuvant chemotherapy in patients with operable urothelial cancer. A Multicenter, Single-arm Phase II Trial.